Rebecca A. Evans
- Oncology top 2%
- Immunology top 5%
- Molecular Biology
- Ophthalmology top 2%
- Cancer Research top 10%
- Co-authors
- Robert H. VonderheideCynthia ClendeninRafael WinogradDavid L. BajorBen Z. StangerSach SokolBarry SkarfMark E. Molitch
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Pancreatic and Hepatic Oncology Research (6 papers)Drug Transport and Resistance Mechanisms (4 papers)
- Cited by
- OncologyImmunologyOphthalmology
- Partner nations
- United StatesUnited KingdomSlovakia
In The Last Decade
Rebecca A. Evans
24 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.2k
- Immunology 697
- Molecular Biology 468
- Ophthalmology 194
- Cancer Research 183
Countries citing papers authored by Rebecca A. Evans
This map shows the geographic impact of Rebecca A. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca A. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca A. Evans more than expected).
Fields of papers citing papers by Rebecca A. Evans
This network shows the impact of papers produced by Rebecca A. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca A. Evans. The network helps show where Rebecca A. Evans may publish in the future.
Co-authorship network of co-authors of Rebecca A. Evans
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca A. Evans. A scholar is included among the top collaborators of Rebecca A. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca A. Evans. Rebecca A. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 21 | |
| 4 | 32 | |
| 5 | 43 | |
| 6 | 53 | |
| 7 | 33 | |
| 8 | 123 | |
| 9 | 44 | |
| 10 | 345 | |
| 11 | 228 | |
| 12 | Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cellsbreakdown → | 407 |
| 13 | 4 | |
| 14 | 69 | |
| 15 | 94 | |
| 16 | 40 | |
| 17 | 42 | |
| 18 | 4 | |
| 19 | 246 | |
| 20 | The interplay of lymphoid cells and macrophages in tumour immunity. | 24 |
About Rebecca A. Evans
Rebecca A. Evans is a scholar working on Oncology, Immunology and Allergy and Immunology, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (697 citations) and Ophthalmology (194 citations). Rebecca A. Evans has collaborated with scholars based in United States, United Kingdom and Slovakia. Frequent co-authors include Robert H. Vonderheide, Cynthia Clendenin, Rafael Winograd, David L. Bajor, Ben Z. Stanger, Sach Sokol, Barry Skarf, Mark E. Molitch, Katelyn T. Byrne and B. Senior. Their work appears in journals such as Gastroenterology, American Journal of Clinical Nutrition and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.